Antibiotic Developments
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. Read more
8 Mar 2024
SIRIO Launches New Consumer Health Gummies at CPHI Barcelona
Sirio Pharma will further expand its offering in the consumer health market, building on last month’s ‘pharma targeted’ softgel launch, with the introduction of a range of herbal gummies for trending consumer health categories. Read more
6 Oct 2023
ANL and SoundCell awarded grant for antibiotic sensitivity test
Applied Nanolayers BV (ANL) and SoundCell BV have received €275,000 R&D funding from Provincie Zuid-Holland to develop a prototype for SoundCell’s high throughput single-cell graphene antibiotic sensitivity test. Read more
27 Mar 2023
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit. Read more
8 Aug 2022
Quidel Corp provides rapid clinical detection of C. difficile infection
The Sofia 2 C. difficile FIA (Fluorescent Immunoassay), from healthcare manufacturer Quidel Corporation, provides accurate detection of C. difficile in 15 minutes – half the time of comparator assays – allowing rapid treatment decisions. Read more
1 Jul 2022
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
CARBOGEN AMCIS Passes Two FDA Inspections at its Manufacturing Sites in Switzerland
Both sites in Neuland and Aarau passed the inspection processes with No Actions Indicated (NAIs) identified. Read more
26 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Finish Thompson highlights drum pumps for pharma applications
Finish Thompson Inc. (FTI), a specialist in the corrosive chemical transfer industry, highlights its SFV drum pump, a cost-effective pump designed for container-to-container transfer of acids, corrosives, and chemicals. Read more
26 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
LYVA Labs' Innovate UK Biomedical Catalyst Microbials Accelerator companies secure £857,000 in funding
Nine innovative businesses have received receiving £857k in funding, from the Innovate UK Biomedical Catalyst feasibility grant, after completing LYVA Labs’ Microbials Accelerator programme - the first Innovate UK programme of its kind in this field. Read more
25 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Broken String Biosciences Appoints New Chief Commercial Officer
The newly appointed Steve Becker will help guide the genomics company as it expands its commercial operations. Read more
25 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sirnaomics announces completion of IND-Enabling studies of safety and efficacy for STP125G with NHP models
Sirnaomics, a leading biopharmaceutical company engaging in the discovery and development of advanced RNAi therapeutics, announced today that it has completed IND-enabling studies for STP125G. Read more
24 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Enterprise Therapeutics Doses First Person with Cystic Fibrosis with ETD001
As part of the Phase 2a trial, ETD001 aims to clear mucus and increase hydration by targeting the epithelial sodium channel. Read more
24 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more